In this study, we showed that full-length eIF4A1 and eIF4A2, sharing exactly 95.3% similarity in amino acid sequences (see Supplementary Figure S5), exhibit different enzymatic properties, which may result in their distinct roles in cancer development. This evidence concerns the gene EIF4A2 and cancer.